Ask.Screen.Know

By  Jonah Comstock 09:47 am March 2, 2015
Going "beyond the pill" doesn't just mean devising new digital technologies to market a drug or promote medication adherence with software tools. Sometimes it means engaging patients in their patient journey long before a drug enters into the equation -- and hoping it pays dividends later on. Jeremy Shepler, senior director of diabetes marketing at Novo Nordisk, spoke at the ePharma Summit last...